China lets yuan rise to strongest level in years as de-dollarisation trend grows



China’s central bank set the yuan’s daily fixing rate at its strongest level since mid-2023 on Wednesday, as the Chinese currency extended gains with investors increasingly rotating out of US dollar assets amid concerns over the Federal Reserve’s independence and US debt sustainability.

The People’s Bank of China set the yuan’s midpoint rate – also known as the daily fixing rate – at 6.9438 to the US dollar, which marked the strongest level in 33 months.

The move followed months of steady appreciation in the yuan, with its offshore rate trading at 6.909 per US dollar as of early afternoon on Wednesday.

By contrast, the US dollar has remained under sustained pressure in recent months, with investor confidence sapped by persistent concerns over the Donald Trump administration’s policy volatility and interventions in the Federal Reserve, as well as the United States’ long-term fiscal sustainability.

Billionaire investor Ray Dalio, founder of the hedge fund Bridgewater Associates, has warned that the US is in stage five – or the “pre-breakdown phase” – of his six-stage “big cycle” that aims to chart the rise and fall of national and global orders.

“We are sort of at the brink but not over the brink,” he said in an interview with Tucker Carlson released on Tuesday. “It’s before a period of great disorder when there can be a monetary breaking down of the system.”

He warned of a looming debt crisis in which the Federal Reserve could be forced to monetise deficits by printing money, eroding the currency’s value.

  • Related Posts

    Stablecoins, wealth platforms launched at Consensus 2026 amid tighter Beijing oversight

    As Consensus 2026 officially kicks off in Hong Kong this week, digital asset firms are rolling out product updates to coincide with one of the industry’s most significant events. Digital…

    Continue reading
    Capital injection: China backs AI drug makers in self-reliance drive

    Hangzhou-based METiS TechBio, founded in 2020, raised 400 million yuan (US$57.9 million) in series D financing in August last year, led by the Beijing Medical and Health Industry Investment Fund…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *